NewAmsterdam Pharma (NAMS) Institutional Ownership → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free NAMS Stock Alerts $21.86 +0.07 (+0.32%) (As of 05/9/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for NewAmsterdam Pharma (NASDAQ:NAMS)CurrentInstitutional OwnershipPercentage89.89%Number ofInstitutional Buyers(last 12 months)16TotalInstitutional Inflows(last 12 months)$263.56MNumber ofInstitutional Sellers(last 12 months)0 Get NAMS Insider Trade Alerts Want to know when executives and insiders are buying or selling NewAmsterdam Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NAMS Institutional Buying and Selling by Quarter Ad InvestorPlace1970’s computer coder Issues Shocking AI WarningLouis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology… Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans.Click here to watch his new video ASAP NewAmsterdam Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/7/2024 TimesSquare Capital Management LLC228,616$5.41M0.1%N/A0.256% 5/2/2024 Jennison Associates LLC930,851$22.02M0.0%N/A1.043% 4/10/2024 Yarbrough Capital LLC23,960$567K0.0%N/A0.027% 3/7/2024 Fcpm Iii Services B.V.11,831,461$132.16M39.2%N/A14.373% 2/15/2024Opaleye Management Inc.265,388$2.96M0.8%N/A0.325% 2/15/2024Parkman Healthcare Partners LLC300,750$3.36M0.5%+20.8%0.369% 2/1/2024Wolverine Asset Management LLC8,694$97K0.0%+197.2%0.011% 11/15/2023Affinity Asset Advisors LLC125,000$1.16M0.3%+25.0%0.153% 11/14/2023Schonfeld Strategic Advisors LLC64,700$598K0.0%+12.9%0.079% 11/13/2023Wolverine Asset Management LLC2,925$27K0.0%N/A0.004% 8/21/2023Affinity Asset Advisors LLC100,000$1.19M0.4%N/A0.123% 8/15/2023RA Capital Management L.P.9,000,000$107.01M2.0%+125.0%11.035% 8/15/2023Bain Capital Life Sciences Investors LLC10,473,913$124.54M12.8%+26.2%12.842% 8/10/2023Monashee Investment Management LLC95,000$1.13M0.3%N/A0.116% 8/4/2023Maven Securities LTD25,000$297K0.0%N/A0.031% 7/19/2023 Medicxi Ventures Management Jersey Ltd2,869,565$34.12M9.6%+43.5%3.518% 7/14/2023Venture Visionary Partners LLC10,000$119K0.0%N/A0.012% 5/9/2023GMT Capital Corp1,083,800$14.37M0.6%+8.4%6.106% 5/8/2023Wolverine Asset Management LLC4,819$64K0.0%N/A0.027% 2/14/2023RA Capital Management L.P.4,000,000$43.60M0.9%N/A22.535% 2/3/2023Frazier Life Sciences Management L.P.9,341,551$101.82M6.3%N/A52.628% 2/3/2023GMT Capital Corp1,000,000$10.90M0.5%N/A5.634% 1/31/2023 Medicxi Ventures Management Jersey Ltd2,000,000$21.80M9.2%N/A11.268% (Data available from 1/1/2016 forward) NAMS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NAMS shares? During the previous two years, 17 institutional investors and hedge funds held shares of NewAmsterdam Pharma. The most heavily invested institutionals were Fcpm Iii Services B.V. ($132.16M), Bain Capital Life Sciences Investors LLC ($124.54M), RA Capital Management L.P. ($107.01M), Frazier Life Sciences Management L.P. ($101.82M), Medicxi Ventures Management Jersey Ltd ($34.12M), Jennison Associates LLC ($22.02M), and GMT Capital Corp ($14.37M).Learn more on NAMS's institutional investors. What percentage of NewAmsterdam Pharma stock is owned by institutional investors? 89.89% of NewAmsterdam Pharma stock is owned by institutional investors. Learn more on NAMS's institutional investor holdings. Which institutional investors have been buying NewAmsterdam Pharma stock? Of the 17 institutional investors that purchased NewAmsterdam Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Fcpm Iii Services B.V. ($11.83M), Frazier Life Sciences Management L.P. ($9.34M), RA Capital Management L.P. ($9M), Medicxi Ventures Management Jersey Ltd ($2.87M), Bain Capital Life Sciences Investors LLC ($2.17M), GMT Capital Corp ($1.08M), and Jennison Associates LLC ($930.85K). How much institutional buying is happening at NewAmsterdam Pharma? Institutional investors have bought a total of 38,076,744 shares in the last 24 months. This purchase volume represents approximately $441.75M in transactions. Related Companies: Syndax Pharmaceuticals Major Shareholders Edgewise Therapeutics Major Shareholders Galapagos Major Shareholders Amneal Pharmaceuticals Major Shareholders Agios Pharmaceuticals Major Shareholders Structure Therapeutics Major Shareholders Amphastar Pharmaceuticals Major Shareholders Evotec Major Shareholders Deciphera Pharmaceuticals Major Shareholders Catalyst Pharmaceuticals Major Shareholders This page (NASDAQ:NAMS) was last updated on 5/9/2024 by MarketBeat.com Staff From Our Partners1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeUrgent Nvidia WarningAltimetryThe Crypto 9-5 Escape PlanCrypto 101 Media348 million Americans lives to END as we know it?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewAmsterdam Pharma Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
